Systematic review shows GLP-1RA therapy reduces weight in patients post-bariatric surgery, suggesting potential metabolic benefits.
GLP-1RAs significantly reduce weight, BMI, HbA1c, and total cholesterol in patients following bariatric surgery. These findings highlight the potential of GLP-1RA therapy post-bariatric surgery. Future research is warranted to assess the long-term effects of GLP-1RA on the post-operative metabolic profile.
No takes yet. Share an insight, caveat, or question.
Bilal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: